Human antibodies binding to RSV G proteins
First Claim
Patent Images
1. An antibody able to specifically bind to attachment glycoprotein (G protein) of a respiratory syncytial virus (RSV) and able to neutralize RSV A2 and B strains, wherein the antibody binds to an epitope within the central conserved domain of the RSV G protein, wherein the antibody is selected from the group consisting of:
- a) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
1, a heavy chain CDR2 region of SEQ ID NO;
2, and a heavy chain CDR3 region of SEQ ID NO;
3, a light chain CDR1 region of SEQ ID NO;
4, a light chain CDR2 region of SEQ ID NO;
5, and a light chain CDR3 region of SEQ ID NO;
6;
b) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
7, a heavy chain CDR2 region of SEQ ID NO;
8, and a heavy chain CDR3 region of SEQ ID NO;
9, a light chain CDR1 region of SEQ ID NO;
10, a heavy chain CDR2 region of SEQ ID NO;
1, and a light chain CDR3 region of SEQ ID NO;
12,c) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
13, a heavy chain CDR2 region of SEQ ID NO;
14, and a heavy chain CDR3 region of SEQ ID NO;
15, a light chain CDR1 region of SEQ ID NO;
16 a light chain CDR2 region of SEQ ID NO;
17, and a light chain CDR3 region of SEQ ID NO;
18;
d) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
19, a heavy chain CDR2 region of SEQ ID NO;
20, and a heavy chain CDR3 region of SEQ ID NO;
21, a light chain CDR1 region of SEQ ID NO;
22, a light chain CDR2 region of SEQ ID NO;
23, and a light chain CDR3 region of SEQ ID NO;
24;
e) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
25, a heavy chain CDR2 region of SEQ ID NO;
26, and a heavy chain CDR3 region of SEQ ID NO;
27, a light chain CDR1 region of SEQ ID NO;
28, a light chain CDR2 region of SEQ ID NO;
29, and a light chain CDR3 region of SEQ ID NO;
30;
f) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
31, a heavy chain CDR2 region of SEQ ID NO;
32, and a heavy chain CDR3 region of SEQ ID NO;
33, a light chain CDR1 region of SEQ ID NO;
34, a light chain CDR2 region of SEQ ID NO;
35, and a light chain CDR3 region of SEQ ID NO;
36;
g) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
37, a heavy chain CDR2 region of SEQ ID NO;
38, and a heavy chain CDR3 region of SEQ ID NO;
39, a light chain CDR1 region of SEQ ID NO;
40, a light chain CDR2 region of SEQ ID NO;
41, and a light chain CDR3 region of SEQ ID NO;
42;
h) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
43, a heavy chain CDR2 region of SEQ ID NO;
44, and a heavy chain CDR3 region of SEQ ID NO;
45, a light chain CDR1 region of SEQ ID NO;
46, a light chain CDR2 region of SEQ ID NO;
47, and a light chain CDR3 region of SEQ ID NO;
48;
i) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
49, a heavy chain CDR2 region of SEQ ID NO;
50 and a heavy chain CDR3 region of SEQ ID NO;
51, a light chain CDR1 region of SEQ ID NO;
52, a light chain CDR2 region of SEQ ID NO;
53, and a light chain CDR3 region of SEQ ID NO;
54;
j) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
55, a heavy chain CDR2 region of SEQ ID NO;
56, and a heavy chain CDR3 region of SEQ ID NO;
57 a light chain CDR1 region of SEQ ID NO;
58, a light chain CDR2 region of SEQ ID NO;
59, and a light chain CDR3 region of SEQ ID NO;
60;
k) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
61, a heavy chain CDR2 region of SEQ ID NO;
62, and a heavy chain CDR3 region of SEQ ID NO;
63, a light chain CDR1 region of SEQ ID NO;
64, a light chain CDR2 region of SEQ ID NO;
65, and a light chain CDR3 region of SEQ ID NO;
66; and
l) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
67, a heavy chain CDR2 region of SEQ ID NO;
68, and a heavy chain CDR3 region of SEQ ID NO;
69 a light chain CDR1 region of SEQ ID NO;
70, a light chain CDR2 region of SEQ ID NO;
71, and a light chain CDR3 region of SEQ ID NO;
72.
2 Assignments
0 Petitions
Accused Products
Abstract
The disclosure provides isolated antibodies and antigen-binding fragments that bind to the G protein of RSV and which are capable of neutralizing RSV.
4 Citations
18 Claims
-
1. An antibody able to specifically bind to attachment glycoprotein (G protein) of a respiratory syncytial virus (RSV) and able to neutralize RSV A2 and B strains, wherein the antibody binds to an epitope within the central conserved domain of the RSV G protein, wherein the antibody is selected from the group consisting of:
-
a) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
1, a heavy chain CDR2 region of SEQ ID NO;
2, and a heavy chain CDR3 region of SEQ ID NO;
3, a light chain CDR1 region of SEQ ID NO;
4, a light chain CDR2 region of SEQ ID NO;
5, and a light chain CDR3 region of SEQ ID NO;
6;b) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
7, a heavy chain CDR2 region of SEQ ID NO;
8, and a heavy chain CDR3 region of SEQ ID NO;
9, a light chain CDR1 region of SEQ ID NO;
10, a heavy chain CDR2 region of SEQ ID NO;
1, and a light chain CDR3 region of SEQ ID NO;
12,c) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
13, a heavy chain CDR2 region of SEQ ID NO;
14, and a heavy chain CDR3 region of SEQ ID NO;
15, a light chain CDR1 region of SEQ ID NO;
16 a light chain CDR2 region of SEQ ID NO;
17, and a light chain CDR3 region of SEQ ID NO;
18;d) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
19, a heavy chain CDR2 region of SEQ ID NO;
20, and a heavy chain CDR3 region of SEQ ID NO;
21, a light chain CDR1 region of SEQ ID NO;
22, a light chain CDR2 region of SEQ ID NO;
23, and a light chain CDR3 region of SEQ ID NO;
24;e) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
25, a heavy chain CDR2 region of SEQ ID NO;
26, and a heavy chain CDR3 region of SEQ ID NO;
27, a light chain CDR1 region of SEQ ID NO;
28, a light chain CDR2 region of SEQ ID NO;
29, and a light chain CDR3 region of SEQ ID NO;
30;f) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
31, a heavy chain CDR2 region of SEQ ID NO;
32, and a heavy chain CDR3 region of SEQ ID NO;
33, a light chain CDR1 region of SEQ ID NO;
34, a light chain CDR2 region of SEQ ID NO;
35, and a light chain CDR3 region of SEQ ID NO;
36;g) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
37, a heavy chain CDR2 region of SEQ ID NO;
38, and a heavy chain CDR3 region of SEQ ID NO;
39, a light chain CDR1 region of SEQ ID NO;
40, a light chain CDR2 region of SEQ ID NO;
41, and a light chain CDR3 region of SEQ ID NO;
42;h) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
43, a heavy chain CDR2 region of SEQ ID NO;
44, and a heavy chain CDR3 region of SEQ ID NO;
45, a light chain CDR1 region of SEQ ID NO;
46, a light chain CDR2 region of SEQ ID NO;
47, and a light chain CDR3 region of SEQ ID NO;
48;i) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
49, a heavy chain CDR2 region of SEQ ID NO;
50 and a heavy chain CDR3 region of SEQ ID NO;
51, a light chain CDR1 region of SEQ ID NO;
52, a light chain CDR2 region of SEQ ID NO;
53, and a light chain CDR3 region of SEQ ID NO;
54;j) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
55, a heavy chain CDR2 region of SEQ ID NO;
56, and a heavy chain CDR3 region of SEQ ID NO;
57 a light chain CDR1 region of SEQ ID NO;
58, a light chain CDR2 region of SEQ ID NO;
59, and a light chain CDR3 region of SEQ ID NO;
60;k) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
61, a heavy chain CDR2 region of SEQ ID NO;
62, and a heavy chain CDR3 region of SEQ ID NO;
63, a light chain CDR1 region of SEQ ID NO;
64, a light chain CDR2 region of SEQ ID NO;
65, and a light chain CDR3 region of SEQ ID NO;
66; andl) an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
67, a heavy chain CDR2 region of SEQ ID NO;
68, and a heavy chain CDR3 region of SEQ ID NO;
69 a light chain CDR1 region of SEQ ID NO;
70, a light chain CDR2 region of SEQ ID NO;
71, and a light chain CDR3 region of SEQ ID NO;
72. - View Dependent Claims (4, 9, 13, 16, 18)
-
-
2. An antigen-binding fragment that specifically binds to the G protein of a respiratory syncytial virus (RSV) and neutralizes RSV A2 and B strains, wherein the antigen-biding fragment is selected from the group consisting of:
-
a) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
1, a heavy chain CDR2 region of SEQ ID NO;
2, and a heavy chain CDR3 region of SEQ ID NO;
3, a light chain CDR1 region of SEQ ID NO;
4, a light chain CDR2 region of SEQ ID NO;
5, and a light chain CDR3 region of SEQ ID NO;
6;b) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
7, a heavy chain CDR2 region of SEQ ID NO;
8, and a heavy chain CDR3 region of SEQ ID NO;
9, a light chain CDR1 region of SEQ ID NO;
10, a heavy chain CDR2 region of SEQ ID NO;
11, and a light chain CDR3 region of SEQ ID NO;
12,c) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
13, a heavy chain CDR2 region of SEQ ID NO;
14, and a heavy chain CDR3 region of SEQ ID NO;
15, a light chain CDR1 region of SEQ ID NO;
16 a light chain CDR2 region of SEQ ID NO;
17, and a light chain CDR3 region of SEQ ID NO;
18;d) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
19, a heavy chain CDR2 region of SEQ ID NO;
20, and a heavy chain CDR3 region of SEQ ID NO;
21, a light chain CDR1 region of SEQ ID NO;
22, a light chain CDR2 region of SEQ ID NO;
23, and a light chain CDR3 region of SEQ ID NO;
24;e) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
25, a heavy chain CDR2 region of SEQ ID NO;
26, and a heavy chain CDR3 region of SEQ ID NO;
27, a light chain CDR1 region of SEQ ID NO;
28, a light chain CDR2 region of SEQ ID NO;
29, and a light chain CDR3 region of SEQ ID NO;
30;f) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
31, a heavy chain CDR2 region of SEQ ID NO;
32, and a heavy chain CDR3 region of SEQ ID NO;
33, a light chain CDR1 region of SEQ ID NO;
34, a light chain CDR2 region of SEQ ID NO;
35, and a light chain CDR3 region of SEQ ID NO;
36;g) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
37, a heavy chain CDR2 region of SEQ ID NO;
38, and a heavy chain CDR3 region of SEQ ID NO;
39, a light chain CDR1 region of SEQ ID NO;
40, a light chain CDR2 region of SEQ ID NO;
41, and a light chain CDR3 region of SEQ ID NO;
42;h) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
43, a heavy chain CDR2 region of SEQ ID NO;
44, and a heavy chain CDR3 region of SEQ ID NO;
45, a light chain CDR1 region of SEQ ID NO;
46, a light chain CDR2 region of SEQ ID NO;
47, and a light chain CDR3 region of SEQ ID NO;
48;i) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
49, a heavy chain CDR2 region of SEQ ID NO;
50 and a heavy chain CDR3 region of SEQ ID NO;
51, a light chain CDR1 region of SEQ ID NO;
52, a light chain CDR2 region of SEQ ID NO;
53, and a light chain CDR3 region of SEQ ID NO;
54;j) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
55, a heavy chain CDR2 region of SEQ ID NO;
56, and a heavy chain CDR3 region of SEQ ID) NO;
57 a light chain CDR1 region of SEQ ID NO;
58, a light chain CDR2 region of SEQ ID NO;
59, and a light chain CDR3 region of SEQ ID NO;
60;k) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
61, a heavy chain CDR2 region of SEQ ID NO;
62, and a heavy chain CDR3 region of SEQ ID NO;
63, a light chain CDR1 region of SEQ ID NO;
64, a light chain CDR2 region of SEQ ID NO;
65, and a light chain CDR3 region of SEQ ID NO;
66; andl) an antigen-binding fragment comprising a heavy chain CDR1 region of SEQ ID NO;
67, a heavy chain CDR2 region of SEQ ID NO;
68, and a heavy chain CDR3 region of SEQ ID NO;
69 a light chain CDR1 region of SEQ ID NO;
70, a light chain CDR2 region of SEQ ID NO;
71, and a light chain CDR3 region of SEQ ID NO;
72. - View Dependent Claims (5, 6, 7, 8, 11, 12, 14)
-
-
3. A functional variant of an antibody that specifically binds to the G protein of a respiratory syncytial virus (RSV) and neutralizes RSV A2 and B strains, wherein the functional variant of an antibody is selected from the group consisting of:
-
a) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
1, a heavy chain CDR2 region of SEQ ID NO;
2, and a heavy chain CDR3 region of SEQ ID NO;
3, a light chain CDR1 region of SEQ ID NO;
4, a light chain CDR2 region of SEQ ID NO;
5, and a light chain CDR3 region of SEQ ID NO;
6;b) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
7, a heavy chain CDR2 region of SEQ ID NO;
8, and a heavy chain CDR3 region of SEQ ID NO;
9, a light chain CDR1 region of SEQ ID NO;
10, a heavy chain CDR2 region of SEQ ID NO;
11, and a light chain CDR3 region of SEQ ID NO;
12,c) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
13, a heavy chain CDR2 region of SEQ ID NO;
14, and a heavy chain CDR3 region of SEQ ID NO;
15, a light chain CDR1 region of SEQ ID NO;
16 a light chain CDR2 region of SEQ ID NO;
17, and a light chain CDR3 region of SEQ ID NO;
18;d) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
19, a heavy chain CDR2 region of SEQ ID NO;
20, and a heavy chain CDR3 region of SEQ ID NO;
21, a light chain CDR1 region of SEQ ID NO;
22, a light chain CDR2 region of SEQ ID NO;
23, and a light chain CDR3 region of SEQ ID NO;
24;e) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
25, a heavy chain CDR2 region of SEQ ID NO;
26, and a heavy chain CDR3 region of SEQ ID NO;
27, a light chain CDR1 region of SEQ ID NO;
28, a light chain CDR2 region of SEQ ID NO;
29, and a light chain CDR3 region of SEQ ID NO;
30;f) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID) NO;
31, a heavy chain CDR2 region of SEQ ID NO;
32, and a heavy chain CDR3 region of SEQ ID NO;
33, a light chain CDR1 region of SEQ ID NO;
34, a light chain CDR2 region of SEQ ID NO;
35, and a light chain CDR3 region of SEQ ID NO;
36;g) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
37, a heavy chain CDR2 region of SEQ ID NO;
38, and a heavy chain CDR3 region of SEQ ID NO;
39, a light chain CDR1 region of SEQ ID NO;
40, a light chain CDR2 region of SEQ ID NO;
41, and a light chain CDR3 region of SEQ ID NO;
42;h) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
43, a heavy chain CDR2 region of SEQ ID NO;
44, and a heavy chain CDR3 region of SEQ ID NO;
45, a light chain CDR1 region of SEQ ID NO;
46, a light chain CDR2 region of SEQ ID NO;
47, and a light chain CDR3 region of SEQ ID NO;
48;i) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
49, a heavy chain CDR2 region of SEQ ID NO;
50 and a heavy chain CDR3 region of SEQ ID NO;
51, a light chain CDR1 region of SEQ ID NO;
52, a light chain CDR2 region of SEQ ID NO;
53, and a light chain CDR3 region of SEQ ID NO;
54;j) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
55, a heavy chain CDR2 region of SEQ ID NO;
56, and a heavy chain CDR3 region of SEQ ID NO;
57 a light chain CDR1 region of SEQ ID NO;
58, a light chain CDR2 region of SEQ ID NO;
59, and a light chain CDR3 region of SEQ ID NO;
60;k) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
61, a heavy chain CDR2 region of SEQ ID NO;
62, and a heavy chain CDR3 region of SEQ ID NO;
63, a light chain CDR1 region of SEQ ID NO;
64, a light chain CDR2 region of SEQ ID NO;
65, and a light chain CDR3 region of SEQ ID NO;
66; andl) a functional variant of an antibody comprising a heavy chain CDR1 region of SEQ ID NO;
67, a heavy chain CDR2 region of SEQ ID NO;
68, and a heavy chain CDR3 region of SEQ ID NO;
69 a light chain CDR1 region of SEQ ID NO;
70, a light chain CDR2 region of SEQ ID NO;
71, and a light chain CDR3 region of SEQ ID NO;
72. - View Dependent Claims (10, 15, 17)
-
Specification